Pharmaceutical Development Group

Pharmaceutical Development Group (PDG), founded in 2005 and based in Boston, is a specialized regulatory consulting firm serving the pharmaceutical and medical device industries. As a subsidiary of Biotech Research Group Corporation, PDG provides end-to-end services to navigate the complex U.S. FDA regulatory landscape, including strategic drug development, submission support, quality compliance, and post-marketing surveillance. The company positions itself as an accessible, long-term partner for clients, leveraging a team of former industry executives and regulatory professionals to optimize product development and commercialization strategies.

Integrated regulatory knowledge and strategic consulting services covering full FDA product lifecycle pathways for drugs, biologics, and medical devices.

PDG competes in the fragmented regulatory affairs consulting market against large, full-service CROs (e.g., IQVIA, Parexel, PPD), specialized regulatory consulting boutiques, and independent consultants. Its differentiation lies in its positioning as an accessible, nimble, and full-lifecycle partner with a focus on urgent regulatory support and hands-on strategic guidance.